ArticleBlood neoplasia2024

Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial.

Timothy S Pardee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.